These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 26026926)

  • 1. Meta-analysis of nocturia and risk of all-cause mortality in adult population.
    Fan Y; Wei F; Lang Y; Qi W
    Int J Cardiol; 2015 Sep; 195():120-2. PubMed ID: 26026926
    [No Abstract]   [Full Text] [Related]  

  • 2. Nocturia: a non-specific but important symptom of urological disease.
    Schneider T; de la Rosette JJ; Michel MC
    Int J Urol; 2009 Mar; 16(3):249-56. PubMed ID: 19226359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Demystifying nocturia: identifying the cause and tailoring the treatment.
    Laureanno P; Ellsworth P
    Urol Nurs; 2010; 30(5):276-86; quiz 287. PubMed ID: 21067093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detrusor overactivity persisting at night and preceding nocturia in patients with overactive bladder syndrome: a nocturnal cystometrogram and polysomnogram study.
    Krystal AD; Preud'homme XA; Amundsen CL; Webster GD
    J Urol; 2010 Aug; 184(2):623-8. PubMed ID: 20639027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Association between nocturia, subjective satisfaction with sleep and insomnia in patients with overactive bladder].
    Espuña-Pons M; Blasco P; Pérez M; Díaz-Cuervo H
    Med Clin (Barc); 2010 Sep; 135(8):357-9. PubMed ID: 20627322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between overactive bladder symptoms and quality of life in Japanese male patients: focus on nocturia.
    Takao T; Tsujimura A; Kiuchi H; Takezawa K; Okuda H; Yamamoto K; Fukuhara S; Miyagawa Y; Nonomura N
    Urology; 2013 Jul; 82(1):189-93. PubMed ID: 23642937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of solifenacin on nocturia in Japanese patients with overactive bladder: impact on sleep evaluated by bladder diary.
    Yokoyama O; Yamaguchi O; Kakizaki H; Itoh N; Yokota T; Okada H; Ishizuka O; Ozono S; Gotoh M; Sugiyama T; Seki N; Yoshida M; Yamada S
    J Urol; 2011 Jul; 186(1):170-4. PubMed ID: 21575976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The evaluation and treatment of nocturia: a consensus statement.
    Weiss JP; Blaivas JG; Bliwise DL; Dmochowski RR; Dubeau CE; Lowe FC; Petrou SP; Van Kerrebroeck PE; Rosen RC; Wein AJ
    BJU Int; 2011 Jul; 108(1):6-21. PubMed ID: 21676145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nocturia in patients with overactive bladder.
    Espuña-Pons M; Blasco P; Pérez M; Rebollo P
    Arch Esp Urol; 2010 Jun; 63(5):363-72. PubMed ID: 20587841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A systematic evaluation of factors associated with nocturia--the population-based FINNO study.
    Tikkinen KA; Auvinen A; Johnson TM; Weiss JP; Keränen T; Tiitinen A; Polo O; Partinen M; Tammela TL
    Am J Epidemiol; 2009 Aug; 170(3):361-8. PubMed ID: 19515794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of pharmacological management of nocturia with non-antidiuretic agents: does statistically significant equal clinically significant?
    Smith AL; Wein AJ
    BJU Int; 2011 May; 107(10):1550-4. PubMed ID: 21518417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of naftopidil for dysuria in benign prostatic hyperplasia and its optimal dose--comparison between 75 and 50 mg.
    Oh-oka H
    Urol Int; 2009; 82(2):136-42. PubMed ID: 19321997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The profiles and patterns of detrusor overactivity and their association with overactive bladder symptoms in men with benign prostatic enlargement associated with detrusor overactivity.
    Shahab N; Seki N; Takahashi R; Kajioka S; Takei M; Yamaguchi A; Naito S
    Neurourol Urodyn; 2009; 28(8):953-8. PubMed ID: 19260093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Nocturia and insomnia. Conflict of interests and methodology].
    Maldonado-Alconada J; Palenzuela-Paniagua SM
    Med Clin (Barc); 2011 Sep; 137(6):284. PubMed ID: 21466886
    [No Abstract]   [Full Text] [Related]  

  • 15. Is type-2 diabetes mellitus associated with overactive bladder symptoms in men with lower urinary tract symptoms?
    Bang WJ; Lee JY; Koo KC; Hah YS; Lee DH; Cho KS
    Urology; 2014 Sep; 84(3):670-4. PubMed ID: 25168549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Devote much attention to improve quality of life of benign prostatic hypertrophy patients with overactive bladder symptoms].
    Liao LM; Na YQ
    Zhonghua Wai Ke Za Zhi; 2010 Dec; 48(23):1761-2. PubMed ID: 21211377
    [No Abstract]   [Full Text] [Related]  

  • 17. [The urodynamic diagnosis of benign prostatic hyperplasia with coexisting overactive bladder].
    Chen Y; DU GH; Chen Z; Cai D; Zhang Q; Yuan XY; Zeng XY; Yang WM; Ye ZQ
    Zhonghua Wai Ke Za Zhi; 2010 Dec; 48(23):1767-70. PubMed ID: 21211379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nocturia in older men.
    van Doorn B; Bosch JL
    Maturitas; 2012 Jan; 71(1):8-12. PubMed ID: 22079871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical observation of holmium laser enucleation of the prostate in the treatment of benign prostatic hyperplasia and overactive bladder].
    Fu G; Liao LM; Hu Y; Li D; Ju YH; Wu J; Liang WL; Xiong ZS
    Zhonghua Wai Ke Za Zhi; 2010 Dec; 48(23):1774-7. PubMed ID: 21211381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of tamsulosin hydrochloride and its mechanism in improving nocturia associated with lower urinary tract symptoms/benign prostatic hyperplasia.
    Yoshida M; Inadome A; Masunaga K; Nagata T; Yoshiyasu T
    Neurourol Urodyn; 2010 Sep; 29(7):1276-81. PubMed ID: 20878997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.